Avnet (AVT) to Report Q2 Earnings: What's in the Offing?

Published on January 24, 2022

Avne's (AVT) Q2 top-line results are likely to have benefited from solid demand for its electronic components, while its cost-reduction programs are anticipated to have boosted the bottom line.

Continue reading on website
Other news

Vertex (VRTX) to Report Q4 Earnings: What's in the Cards?

January 24, 2022
Investors are likely to focus on Vertex Pharmaceuticals' (VRTX) CF product revenues, especially sales of its triple combo CF drug Trikafta/Kaftrio, and non-CF pipeline progress.

Medtronic (MDT) Undertakes Investment to Advance STEM Education

January 24, 2022
The Medtronic Foundation, solely funded by Medtronic plc (MDT), entered into 13 new partnerships to bridge the inequity in STEM education among underrepresented and underserved communities.